Serum testosterone level is a useful biomarker for determining the optimal treatment for castration-resistant prostate cancer.
Hashimoto K, Tabata H, Shindo T, Tanaka T, Hashimoto J, Inoue R, Muranaka T, Hotta H, Yanase M, Kunishima Y, Takahashi A, Masumori N; Sapporo Medical University Urologic Oncology Consortium (SUOC).
Hashimoto K, et al. Among authors: tabata h.
Urol Oncol. 2019 Jul;37(7):485-491. doi: 10.1016/j.urolonc.2019.04.026. Epub 2019 May 16.
Urol Oncol. 2019.
PMID: 31103335